Schering Fails To Thwart Securities Suit Over Vytorin

Law360, New York (June 22, 2010, 6:28 PM EDT) -- A federal judge will not reconsider his decision to allow a securities suit alleging Schering-Plough Corp. hid or misstated the relatively poor performance of its anti-cholesterol drug Vytorin, even in light of the U.S. Supreme Court's decision in Ashcroft v. Iqbal.

The investors adequately pled their case, Judge Denis M. Cavanaugh of the U.S. District Court for the District New Jersey said in an order Monday that upheld an earlier order to allow the case to go forward.

Schering-Plough had asked the judge to reconsider his...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.